Related Experiment Video
Updated: May 8, 2026
09:18
A Sensitive Method to Quantify Senescent Cancer Cells
Published on: August 2, 2013
Stems cells and the pathways to aging and cancer
Derrick J Rossi1, Catriona H M Jamieson, Irving L Weissman
1Immune Disease Institute, Harvard Stem Cell Institute, and the Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. rossi@idi.harvard.edu
Cell
|February 26, 2008
Summary
Aging tissue stem cells decline, impacting organ function and leading to age-related diseases. This study explores the mechanisms behind stem cell aging and its role in disease pathogenesis.
Area of Science:
- Gerontology
- Stem Cell Biology
- Molecular Biology
Background:
- Tissue and organ integrity decline with age.
- Stem cell aging is a key factor in this decline.
- Understanding stem cell aging is crucial for addressing age-related diseases.
Purpose of the Study:
- To investigate the link between stem cell dysfunction and aging.
- To elucidate the mechanisms of stem cell aging.
- To understand the contribution of stem cell decline to disease pathogenesis.
Main Methods:
- Review of existing scientific literature.
- Analysis of evidence linking stem cell dysfunction to aging.
- Focus on pathophysiological conditions and disease mechanisms.
Main Results:
- Stem cell aging contributes significantly to the decline of tissue and organ function.
- Dysfunctional stem cells play a role in the development of age-related diseases.
- Specific mechanisms of stem cell decline are identified.
Conclusions:
- Stem cell aging is a central process in age-related functional decline.
- Targeting stem cell aging may offer therapeutic strategies for age-related diseases.
- Further research into stem cell mechanisms is warranted.
More Related Videos
Related Concept Videos
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...